Close Menu

NEW YORK – Canadian diagnostics company SQI Diagnostics said on Tuesday that certain insiders have exercised their common share purchase warrants for gross proceeds to the company of about C$4 million (US$3.1 million).

The Toronto-based firm said 19,074,997 common share purchase warrants were exercised, of which 18.5 million were exercised at C$.21 per common share pursuant to a private placement of units of the company on March 10, 2017, and 574,997 warrants were exercised at C$.20 per common share. Those warrants were issued on Dec. 20, 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.